Back

Tissue-specific 3 prime end-adenylation of miR-125b mediates cell survival

Blahna, M. T.; Neel, J.-C.; Yu, G.; Louie, J.; Ghatpande, P.; Lagna, G.; Hata, A.

2019-06-15 molecular biology
10.1101/672436 bioRxiv
Show abstract

Next-generation sequencing has uncovered microRNAs (miRNAs) that undergo sequence modifications, known as isomiRs. Their physiological significance, however, remains uncertain, partly because they generally comprise a small fraction of total miRNAs. Here we report that more than 60% of miR-125b, one of the most abundant miRNAs in vascular smooth muscle cells (vSMC), exists as an edited isoform containing a non-templated adenosine residue at the 3 prime-end (miR-125b+A). The properties of miR-125b+A, such as stability and subcellular localization, are similar to those of canonical miR-125b, but miR-125b+A more potently inhibits the expression of a subgroup of targets, including the apoptosis effector Caspase-6 (CASP6). In the CASP6 transcript, adenylated miR125b preferentially targets a conserved, atypical site, with an unusual 36 nucleotides loop between seed sequence and 3 prime-end supplementary site. PAP associated domain containing 2 (PAPD2) is responsible for monoadenylation of miR-125b. Downregulation of PAPD2 results in the conversion of miR-125b+A to miR-125b, derepression of CASP6, and sensitization of vSMC to apoptotic stimuli. Thus, atypical site recognition by a tissue-specific isomiR fulfills a pro-survival role.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 11%
17.8%
Similar papers in this journal
2
eLife
● 5828 papers in training set
Top 9%
11.5%
Similar papers in this journal
3
Nucleic Acids Research
◐ 1281 papers in training set
Top 3%
6.0%
Similar papers in this journal
4
iScience
○ 1154 papers in training set
Top 2%
5.3%
Similar papers in this journal
5
Journal of Biological Chemistry
○ 690 papers in training set
Top 2%
5.3%
Similar papers in this journal
6
Cell Reports
○ 1498 papers in training set
Top 8%
5.0%
50% of probability mass above
7
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 15%
3.4%
8
Communications Biology
○ 993 papers in training set
Top 5%
3.3%
9
Scientific Reports
○ 3612 papers in training set
Top 30%
3.3%
10
Molecular Cell
○ 350 papers in training set
Top 2%
3.1%
11
Science Advances
● 1243 papers in training set
Top 12%
3.1%
12
Molecular and Cellular Biology
○ 47 papers in training set
Top 0.2%
2.6%
13
Oncogene
○ 85 papers in training set
Top 0.9%
2.0%
14
Molecular Therapy - Nucleic Acids
○ 25 papers in training set
Top 0.3%
1.9%
15
EMBO Reports
○ 263 papers in training set
Top 3%
1.8%
16
RNA Biology
○ 78 papers in training set
Top 0.8%
1.4%
17
PLOS Genetics
● 862 papers in training set
Top 10%
1.1%
18
RNA
● 189 papers in training set
Top 1%
1.1%
19
PLOS ONE
● 5266 papers in training set
Top 54%
1.1%
20
Cells
○ 249 papers in training set
Top 6%
1.0%
21
The EMBO Journal
○ 309 papers in training set
Top 5%
1.0%
22
NAR Cancer
◐ 37 papers in training set
Top 0.8%
0.8%
23
Genes & Development
● 90 papers in training set
Top 2%
0.8%
24
Oncogenesis
○ 12 papers in training set
Top 0.4%
0.8%
25
Molecular Therapy Nucleic Acids
○ 39 papers in training set
Top 0.9%
0.8%
26
Molecular Cancer
○ 16 papers in training set
Top 0.4%
0.8%
27
Life Science Alliance
● 285 papers in training set
Top 8%
0.8%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.